Kepos Capital LP Windtree Therapeutics Inc Transaction History

Kepos Capital LP

  • $388 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.38 - $1.14 $62,700 - $188,099
-165,000 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$2.14 - $6.18 $160,500 - $463,500
75,000 Added 83.33%
165,000 $404,000
Q2 2020

Aug 10, 2020
BUY
$3.3 - $9.96 $297,000 - $896,400
90,000 New
90,000 $630,000

Others Institutions Holding WINT

# of Institutions
2
Shares Held
4.09K
Call Options Held
0
Put Options Held
0
View Full List

About WINDTREE THERAPEUTICS INC

WINT Quotes by TradingView
  • Ticker WINT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,627,900
  • Market Cap $113M
  • Description
  • Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...
More about WINT
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email